2/15/2013

The FDA has granted Teva Pharmaceutical Industries approval for its generic form of Shire's attention-deficit/hyperactivity disorder drug Adderall XR in six strengths. Teva has sold an authorized generic since 2009 and is not launching its own yet. The agreement between Teva and Shire ends next year.

Related Summaries